Literature DB >> 15823063

C-type natriuretic peptide inhibits constrictive remodeling without compromising re-endothelialization in balloon-dilated renal arteries.

Andreas Kühnl1, Jaroslav Pelisek, Wen Tian, Michael Kuhlmann, Pierre H Rolland, Choukri Mekkaoui, Alexandra Fuchs, Sigrid Nikol.   

Abstract

PURPOSE: To investigate the long-term effect of local, liposome-mediated gene transfer of C-type natriuretic peptide (CNP) plasmid versus CNP protein on restenosis in porcine renal arteries following balloon angioplasty.
METHODS: The renal arteries of 15 pigs were dilated and the adventitia at the site of balloon injury injected with CNP protein, pCR3.1 plasmid encoding CNP, or the beta-galactosidase gene (control) via a needle injection catheter. Five animals receiving the CNP and control genes in dilated arteries were sacrificed after 3 weeks to analyze re-endothelialization, proliferation, and early CNP expression. Ten animals designated for the long-term experiments (3 months) were treated with the CNP gene versus CNP protein (n=3), the CNP gene versus the control gene (n=3), and the CNP protein versus the control gene (n=3). One animal served as a dilated non-treated control. Transfection and expression of CNP and beta-galactosidase were measured by polymerase chain reaction (PCR) and reverse transcription PCR. Renal arterial lumen narrowing was measured with angiography and histology. Endothelialization was assessed using Evans blue stain; vWF, CD31, factor VIII, and Ki67 were markers for immunohistochemical analysis.
RESULTS: An intact endothelial layer was seen at 3 weeks following angioplasty in all transfected arteries. Three months following treatment, computer-assisted morphometric analysis revealed significant enlargement of the arterial cross-sectional areas in CNP plasmid- treated vessels compared to dilated but untreated arteries (CNP plasmid +34.8%+/-13.9% versus CNP protein -1.75%+/-19.9% versus beta-galactosidase -47.0%+/-13.9%, p<0.01). Angiographic analysis showed significant enlargement of the arterial diameter compared to dilated, untreated arteries (CNP plasmid +20.8%+/-6.8% versus CNP protein +5.7%+/-6.0% versus beta-galactosidase -24.5%+/-10.2%, p<0.01).
CONCLUSIONS: Local application of CNP plasmid proved superior to CNP protein in producing rapid re-endothelialization and significantly enlarging the renal arterial lumen following dilation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823063     DOI: 10.1583/1384R.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  6 in total

Review 1.  Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.

Authors:  Ines Pagel-Langenickel; Jens Buttgereit; Michael Bader; Thomas H Langenickel
Journal:  J Mol Med (Berl)       Date:  2007-04-12       Impact factor: 4.599

Review 2.  C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target.

Authors:  Natalie G Lumsden; Rayomand S Khambata; Adrian J Hobbs
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

3.  Comparative measurement of CNP and NT-proCNP in human blood samples: a methodological evaluation.

Authors:  Andreas Kuehnl; Jaroslav Pelisek; Martin Bruckmeier; Wajima Safi; Hans-Henning Eckstein
Journal:  J Negat Results Biomed       Date:  2013-04-01

4.  Weekly doxorubicin increases coronary arteriolar wall and adventitial thickness.

Authors:  Delrae M Eckman; R Brandon Stacey; Robert Rowe; Ralph D'Agostino; Nancy D Kock; David C Sane; Frank M Torti; Joseph Yeboah; Susan Workman; Kimberly S Lane; W Gregory Hundley
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

5.  Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide.

Authors:  Rayomand S Khambata; Catherine M Panayiotou; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 6.  Nanoparticulate carriers for the treatment of coronary restenosis.

Authors:  Luis Brito; Mansoor Amiji
Journal:  Int J Nanomedicine       Date:  2007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.